skip to main content

Oral Midazolam Dental — ORE Part 1 MCQ

Instant feedback + full explanation. One question, done properly.

HardPharmacology & TherapeuticsOral Midazolam DentalORE Part 1

An ASA I adult with severe dental anxiety is being considered for oral midazolam before elective dental treatment in a UK primary-care setting. Which statement best reflects current UK dental sedation practice?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: AUse an individually assessed oral midazolam regimen within a monitored conscious-sedation service led by a clinician competent in intravenous sedation.

Explanation lettering: E = shown as B · B = shown as E

**A is correct.** UK guidance does not specify a universal fixed adult oral-midazolam dose for dental premedication. Sedation technique and dosing must follow pre-assessment, clinical need and an appropriate monitored conscious-sedation pathway. Oral midazolam is less favoured than titratable techniques because absorption and bioavailability are variable and the dose cannot be titrated to effect; its use requires competence in intravenous sedation, with rescue arrangements including flumazenil. Therefore a fixed dose in B or C cannot be called the standard regimen for every adult. D is unsafe because it explicitly omits monitoring and recovery assessment. E is incompatible with individual professional prescribing, assessment and consent. The discriminating point is that UK dental practice governs oral midazolam as an individually assessed sedation technique, not as a single routine pre-operative dose.

Reference: Scottish Dental Clinical Effectiveness Programme (SDCEP). Conscious Sedation in Dentistry: Guidance Development Methodology, section 3.1, 2017. https://www.sdcep.org.uk/media/oxtb4tut/sdcep-conscious-sedation-methodology.pdf